- Home
- PRGO vs BTT Comparison
PRGO vs BTT Comparison
Compare PRGO & BTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- BTT
- Stock Information
- Founded
- PRGO 1887
- BTT 2012
- Country
- PRGO Ireland
- BTT United Kingdom
- Employees
- PRGO N/A
- BTT N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- BTT Investment Managers
- Sector
- PRGO Health Care
- BTT Finance
- Exchange
- PRGO Nasdaq
- BTT Nasdaq
- Market Cap
- PRGO 1.7B
- BTT 1.4B
- IPO Year
- PRGO 1991
- BTT N/A
- Fundamental
- Price
- PRGO $13.41
- BTT $22.50
- Analyst Decision
- PRGO Buy
- BTT
- Analyst Count
- PRGO 4
- BTT 0
- Target Price
- PRGO $22.50
- BTT N/A
- AVG Volume (30 Days)
- PRGO 4.5M
- BTT 151.1K
- Earning Date
- PRGO 11-05-2025
- BTT 01-01-0001
- Dividend Yield
- PRGO 8.64%
- BTT 2.95%
- EPS Growth
- PRGO N/A
- BTT N/A
- EPS
- PRGO N/A
- BTT N/A
- Revenue
- PRGO $4,281,800,000.00
- BTT N/A
- Revenue This Year
- PRGO $2.12
- BTT N/A
- Revenue Next Year
- PRGO $0.49
- BTT N/A
- P/E Ratio
- PRGO N/A
- BTT N/A
- Revenue Growth
- PRGO N/A
- BTT N/A
- 52 Week Low
- PRGO $12.17
- BTT $18.90
- 52 Week High
- PRGO $30.93
- BTT $21.86
- Technical
- Relative Strength Index (RSI)
- PRGO 26.03
- BTT 52.24
- Support Level
- PRGO $12.17
- BTT $22.19
- Resistance Level
- PRGO $14.50
- BTT $22.60
- Average True Range (ATR)
- PRGO 0.47
- BTT 0.16
- MACD
- PRGO 0.06
- BTT -0.00
- Stochastic Oscillator
- PRGO 44.55
- BTT 53.45
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About BTT BlackRock Municipal 2030 Target Term Trust
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.